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ABSTRACT 
Mixed ligands metal (II) complexes of Ofloxacin (OFL) and Metronidazole (MET) were synthesized and 
characterized by percentage metal analysis using complexometric titration method, infrared and electronic 
spectroscopies, magnetic susceptibility, melting points and conductance measurements. Infrared spectral data 
established that coordination was through OFL’s carboxy group oxygen and the pyridone carbonyl oxygen and 
MET’s imidazole nitrogen atom N and the hydroxyl oxygen atom of the terminal ethanol group. The magnetic 
susceptibility and electronic spectral data indicated that the metal (II) complexes have octahedral geometries 
while the low values of their molar conductance measurement suggest their non-electrolyte nature. The in-vitro 
antimicrobial studies were carried out against clinical strains of Staphylococcus aureus, Enterotoxigenic 
Escherichia. coli, Enteropathogenic Escherichia. coli , Klebsiella pneumonia, Leclercia adecarboxylata, 
Morganella morganii, Salmonella typhi and one fungus (Trichophyton rubrum) showed enhancement in 
antimicrobial activities of the free ligands through coordination to the metals as all the complexes exhibited 
better antimicrobial activities than the free ligands with the cobalt complex [Co(OFL)(MET)(H2O)2]  showing 
the best activity at the concentration of 100 µg/ml. 
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INTRODUCTION 
Combinations of antibiotics offer a helpful 
strategy to deal with the widespread emergence of 
antibiotic- resistant strains of microorganisms 
(Tyers and Wright, 2019). The recognition that no 
antibiotic compound is universally efficacious for 
all infections is an important driver in combining 
antibiotics in order to provide better effectiveness 
over individual compounds (Tyers and Wright, 
2019). The fluoroquinolones are class of 
antimicrobial agents with a broad range of 
antibacterial activity against gram-negative species, 
but are less potent against some anaerobic 
pathogens and several gram-positive strains such as 
staphylococci and streptococci (Zhanel et al., 2002; 
Mitscher, 2005). Thus, there is a significant interest 
in combinations of other antimicrobial agents with 
fluoroquinolones to improve their antibacterial 
spectrum of activity in clinical situations (Acar, 
2000). For example, in mixed aerobic-anaerobic 
infections such as aspiration pneumonia or intra-
abdominal infections, in which initial therapy has 
to be empirical (Reller et al., 2009). Metronidazole 
(MET) (Fig.1a) has an antibacterial spectrum that 
includes most anaerobes (Nguyen et al., 2000). 
Therefore, metronidazole combination with 
ofloxacin (OFL) (Fig.1b) a fluoroquinolone will 
expand its antibacterial spectrum (Stein and 
Goldstein, 2006). 
 
The complexes of antibiotics with metal 
ions offer great opportunities in medicine. This is 
probably because many drugs possess modified 
pharmacological and toxicological properties when 
they appear in the form of metal complexes (Guerra 
et al., 2016; Yu et al., 2016; Mohler et al., 2017; 
Nazir et al., 2018; Shahabadi et al., 2019). Thus, 
the use of metallo-antibiotics allows for reduction 
of dose introduced into the body, enhancement of 
bioavailability and benefiting from the 
pharmaceutical effects of both ligand antibiotics 
and metal ions (Ramotowska et al., 2020).  
Numerous studies regarding the interaction 
between quinolones with several metallic cations 
have been reported in the literature (Meggers, 
2007; Gaber et al., 2012; Xiao et al., 2013). The 
chelation of certain metal ions through the carbonyl 
and carboxyl group of quinolones plays an 
important biological role (Park et al., 2000). 
Ofloxacin (OFL) (Fig.1b) is a second-generation 
quinolone antibiotic which is currently among the 
most frequently used fluoroquinolone drugs (Abd-
Allah et al., 2000; Dinakaran et al., 2008) with 
broad spectrum antibacterial activity, which acts as 
a specific inhibitor of  bacterial DNA-gyrase, the 
enzyme responsible for converting double-stranded 
DNA into a negative super helical form (Sagdinc 
and Bayari, 2004 ). Studies of interaction between 
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ofloxacin and several metal cations commonly 
found in several drugs used as antacids have been 
reported (Park et al., 2000; Macias et al., 2001; 
Macias et al., 2002; Turel, 2002; Serafin and 
Stańczak, 2009). 
Similarly, metronidazole (Fig.1a) is an 
antibiotic from the group of nitroimidazole 
derivatives which is effective in the treatment of 
diseases caused by anaerobic bacteria (Kalinowska-
Lis et al., 2015). It was reported that complexation 
of metronidazole with metals often protects it 
against enzymatic degradation (Athar et al., 2005). 
Also, the increase efficacy of anti-amoebic activity 
of metronidazole was enhanced by metal 
complexation with Pd(II), Pt(II), and Cu(II) (Bharti 
et al., 2002)  
In a bid to expand the antibacterial 
spectrum of ofloxacin against anaerobic bacteria in 
aerobic/anaerobic clinical condition, we hereby 
report the synthesis, characterization, and the 
antimicrobial properties of metal (II) complexes of 
















Figure 1: Structure of Ligands 
 
MATERIALS AND METHODS 
Materials and reagents.  
All reagents and solvents were of 
analytical grade and used without further 
purification. Ofloxacin and Metronidazole were 
obtained from Unique pharmaceutical, Ogun State, 
Nigeria and Bond Pharmaceutical Company Plc, 
Awe, Oyo State, Nigeria. Cobalt (II) Chloride 
hexahydrate, Copper (II) Sulphate pentahydrate, 
Manganese (II) Chloride tetrahydrate, Nickel (II) 
Chloride hexahydrate and Zinc (II) sulphate 




The electronic spectra of the complexes in 
ethanol were recorded on a Perkin-Elmer Lambda 
25 Spectrophotometer and infrared spectra were 
recorded as nujol mull on a Perkin-Elmer BX II 
FT-IR spectrometer 4000–400 cm−1. The room 
temperature magnetic susceptibilities at 303K were 
measured on Sherwood susceptibility balance MSB 
Mark 1 and diamagnetic corrections were 
calculated using Pascal’s constant, melting points 
were determined with Stuart SMP10 Melting point 
apparatus and conductivity measurement was 
obtained using a Labtech Digital ST3100C-F bench 
top conductivity meter in 1 x 10-3M solutions of 
nitromethane. Metal analysis was determined by 
complexometric titration using EDTA solution, 
murexide indicator and ammonia/ammonium chloride 
buffer. 
 
Synthesis of Metal Complexes of 
[M(OFL)(MET).2H2O], where M = Cu(II), 
Co(II), Mn(II),Ni(II) and Zn(II):  
Previously reported procedures were 
employed with slight modification (Ogunniran et 
al., 2008; Osowole et al., 2015). 0.3610g (1mmole) 
of Ofloxacin (OFL) and 0.1711g (1mmole) of 
Metronidazole (MET) were dissolved in 10mL 
ethanol. To the mixed antibiotics solution was 
added (1mmole) equimolar amount of the 
respective metal (II) salt in 10mL ethanol. The 
resulting homogeneous solution was refluxed for 3 
hrs and then cooled in ice. The resulting precipitate 
was filtered, washed with ethanol and dried over 
silica gel.  
 
Antimicrobial Studies.  
Antibacterial screening of the free ligands 
and the synthesized complexes were tested in vitro 
using Agar diffusion method (Chaudhary et al., 
2003; Shahzadi et al., 2006). The prepared culture 
plates were inoculated with different identified 
clinical strains of gram positive and gram negative 
bacteria: Staphylococcus aureus, Enterotoxigenic 
E. coli, Enteropathogenic E. coli, Klebsiella 
pneumonia, Leclercia adecarboxylata, Morganella 
morganii, Salmonella typhi and one fungus 
(Trichophyton rubrum). The bacteria were cultured 
using the pour-plate method. From the diluted 
organisms (10-2) 0-2ml was injected into the 
prepared sterile nutrient agar which was at 45oC, 
then aseptically poured into sterile petri dishes, 
which were allowed to solidify for about 45-
60minutes.  
Wells were made on the agar surface 
(Nutrient agar) with 6mm sterile cork borer. The 
prepared different graded concentrations of the 
complexes and the ligands were poured into the 
well using sterile syringes. The plates were 
incubated at 37 ºC ± 2 ºC for 24 hours. The plates 
were observed for the zone clearance around the 
wells. The zone of inhibition was calculated by 
measuring the diameter of the inhibition zone 
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around the well (in mm) including the well 
diameter. The experiments were conducted in 
triplicates with Gentamycin used as positive 
control. 
Sterile Sabourad Dextrose Agar was 
prepared for Fungus culture, the prepared agar was 
poured into sterile plates in triplicates allowed to 
set properly. 0.2 ml of the organism ((Trichophyton 
rubrum) was spread to cover the surface of the 
agar. Wells were also made using sterile cork borer 
of 6mm in diameter, followed by the introduction 
of the prepared concentrations of the ligands and 
their complexes. The plates were left on the bench 
for 2hours to allow pre diffusion and then 
incubated at 25 ± 2 ºC for 48hours.  Tioconazole 
was used as the reference drug. 
    
RESULTS AND DISCUSSION 
The reaction of the Ofloxacin (OFL), 
Metronidazole (MET) with the metal (II) salts of 
Mn, Ni, Co, Zn, and Cu gave varying shades of 
coloured complexes in low to moderate yields 
(20.24-95.32%) as given in the Table 1 below. The 
ligands, Ofloxacin (OFL) and Metronidazole 
(MET) melted at 250-252°C and 160-162°C 
respectively, whereas their metal complexes all 
decomposed in the range 182- 232 °C. They are 
insoluble in most solvents and but are soluble in 
DMSO and slightly soluble in ethanol. The low 
values of the molar conductivity of the compounds in 
the range 10-18 Ω-1cm2 mol-1 indicate that they are non-
electrolyte in solution (Golcu et al., 2005). The 
analytical data are summarized in Table1. 
 













Ofloxacin (OFL) 361.37 Off White _ 250-252 _ _ _ 
Metronidazole (MET) 171.15 Light Yellow _ 160-162 _ _ _ 
[Cu(OFL)(MET)(H2O)2] 630.06 Green 68.23 232*  10.02(10.07) 1.83 18 
[Ni(OFL)(MET)(H2O)2] 625.21 Light Green 35.08 202* 9.42 (9.39) 2.92 17 
[Co(OFL)(MET)(H2O)2] 625.45 Pink 95.32 192* 9.37 (9.42) 4.52 14 
[Mn(OFL)(MET)(H2O)2]. 
H2O 
639.45 Yellow 87.98 182* 8.45 (8.59) 5.70 10 
[Zn(OFL)(MET)(H2O)2] 631.93 White 16.24 200* 10.41(10.35) D 13 
 D = diamagnetic, *= decomposition temperature, Molar conductance (^m) = ohm- 1 cm 2 mol-l, Exp = 
experimental, μeff = effective magnetic moments, M. Pt = melting point. 
  
Infrared Spectra Studies of Synthesized 
Complexes 
The relevant infrared data are presented in 
Table 2. IR spectra of Ofloxacin (OFL), 
Metronidazole (MET) and their metal complexes 
were studied and assigned based on careful 
comparison of their spectra. A strong band at 1713 
cm-1 due to the stretching vibrations of carboxy 
carbonyls (√C=O in COOH) in OFL was shifted to a 
lower wave number (1631-1573 cm-1) in the metal 
complexes showing the participation of the carboxy 
groups in complex formation (Dorofeev, 2004). 
Similarly, a bathochromic shift of the conjugated 
keto carbonyl that is √(C=O) (pyridone) from 1621 
cm-1 in free ofloxacin to 1580-1549 cm-1 upon 
bonding suggest coordination to the metals through 
the pyridone carbonyl oxygen (Dorofeev, 2004; 
Psomas, 2008). Likewise, on comparison of the 
spectrum of free MET and the spectra of the 
complexes, the strong bands at 3215cm-1 attributed 
to O-H str vibration of the terminal ethanol group 
of MET disappeared in the spectra of the 
complexes which suggest that this group was 
involved in coordination (Masciocchi et al., 2001; 
Berg, 2007; Al-Khodir and Refat, 2017).  The 
bathochromic shift of √(C=N) band of the 
imidazole group at 1535cm-1 of free metronidazole 
ligand to lower wave numbers (1533–1523 cm–1) in 
the spectra of the complexes also indicate 
coordination through the imidazole nitrogen atom 
with the metal ions. 
All the complexes exhibit broad bands in 
the range of 3300–3389 cm−1, which can be 
attributed to the presence of coordinated water 
molecules (Rîmbu et al., 2014). The appearance of 
new bands at about 557-503cm-1 and 499-420 cm-1 
are assigned to M-N and M-O vibrations, 
respectively which support the involvement of N 
and O atoms in complexation with metal ions under 
investigation (Sujarani, S and Ramu, 2015; 
Osowole et al., 2015). 
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Ofloxacin(OFL)     _ 2923,2853(s) 1713(s) 1621(s)     _ 1287(m) _ _ 
Metronidazole(MET) 3215(s)  2923, 2853(s)    _ _ 1535(s) _ _ _ 
[Cu(OFL)(MET)(H2O)2] 3371(b) 2924,2854(s) 1622(s) 1580(s) 1523(s) 1274(m) 513(s) 476(s) 
[Ni(OFL)(MET)(H2O)2] 3373 (b) 2924,2854(s) 1573(s) 1549(s) 1526(s) 1281(m) 507(s) 460(m) 
[Co(OFL)(MET)(H2O)2] 3300 (b) 2923,2853(s) 1625(s) 1573(s) 1533(s) 1277(m) 557(s) 499(m) 
[Mn(OFL)(MET)(H2O)2]. H2O 3389 (b) 2924, 2854(s) 1622(s) 1579(s) 1524(s) 1278(m) 505(s) 420(s) 
[Zn(OFL)(MET)(H2O)2] 3348 (b) 2923,2854(s) 1631(s) 1574(s) 1531(s) 1232(m) 503(s) 465(s) 
b = broad, s = strong, m= medium 
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Electronic Spectra and Magnetic Moments of 
the Synthesised Complexes 
The ultraviolet spectra of Ofloxacin (OFL) 
and Metronidazole (MET) were characterized by 
strong absorption maxima at 33670, 32258 and 
30303 cm-1 assigned to π→ π* and n→ π*  
transitions respectively. In the metal complexes, 
these bands shifted to lower wave number due to 
coordination as presented in Table 3. The electronic 
absorption spectra of manganese-complex 
[Mn(OFL)(MET)(H2O)2].H2O presents three major 
absorptions maxima at 28571, 20000, 13123cm-1 
which were assigned to 6A1g→4A1g, 6A1g→ 4T2g and 
6A1g→4T1g  transitions (Singh and Chaudhary 2004; 
Sreekanth, et al., 2006), Its room temperature 
magnetic moment value of 5.70 B.M in the 
expected range of octahedral geometry around the 
central metal ions (Patel et al., 2005; Kurmoo, 
2009) further typified the existence of octahedral 
configuration. 
The electronic spectra of the Cu(II) 
complexes (Table 3) showed low energy bands at 
18050cm−1 attributed to 2Eg → 2T2g 
transition(Scotti et al., 2015). The low-energy band 
in this position is expected for an octahedral 
configuration and strong high energy band at 
42100cm-1 to metal to ligand charge transfer 
transitions (Prasad and Agarwal, 2007). Also, the 
magnetic moment values 1.83 BM are indicative of 
octhahedral configuration. Hence, the Cu (II) 
complexes appear to be in the octahedral geometry 
(Bagihalli et al., 2008). 
The Co(II) complex exhibited three bands 
at 12690, 19920 and 20661cm-1, assigned to, 
4T1g(F)→ 4T2g(F) , 4T1g(F)→ 4A2g(F) and 4T1g(F)→ 4T1g(P)  
transitions of an octahedral geometry (Osowole et 
al., 2015). An observed moment of 4.52 B.M was 
complimentary of this geometry. The Nickel 
complex [Ni(OFL)(MET)(H2O)2]  displayed two 
absorption bands typical of an octahedral geometry 
at 15151and 29411cm-1 which were assigned to 
3A2g(F)→3T1g(F) and 3A2g(F)→3T1g(P) transitions 
respectively. Usually, square planar Ni(II) 
complexes are diamagnetic while octahedral and 
tetrahedral complexes are paramagnetic with 
moments in the range 2.90- 3.40 B.M and 3.50- 
4.10 B.M respectively. The Ni(II) complex studied 
in this work had a moment of 2.92 B.M. and hence 
have octahedral geometry (Masoud et al., 2008; 
Khann and Asnani, 2011). 
The Zn(II) complex showed only the 
Charge transfer transitions from Metal to ligand, as 
no d-d transition is expected owing to its d10 
configuration. This complex was expectedly 
diamagnetic and assumed a 6-coordinate octahedral 
geometry (Raman et al., 2001; Onah et al., 2011).  
 
 
Table 3: Electronic spectra data of Ofloxacin, Metronidazole and their complexes 
compound UV bands (cm-1) Probable transitions 





































4T1g(F)→ 4T1g(P)  
4T1g(F)→ 4A2g(F)  
4T1g(F)→ 4T2g(F)  
 
 






























where M= Cu, Co, Mn, Ni, Zn and n= 0 or 1
 
Figure 2: Proposed Structure of Metal (II) Complexes of Mixed Ligands of Ofloxacin and Metronidazole 
 
Antimicrobial Studies 
The Ofloxacin (OFL), Metronidazole 
(MET) and their metal complexes were screened 
for their antimicrobial activities against clinical 
strains of Staphylococcus aureus, Enterotoxigenic 
Escherichia. coli, Enteropathogenic Escherichia. 
coli, Klebsiella pneumonia, Leclercia 
adecarboxylata, Morganella morganii, Salmonella 
typhi and one fungus (Trichophyton rubrum) The 
antimicrobial activities of the ligands and their 
metal complexes are presented in Table 4.  
Generally, all the metal complexes of 
mixed ofloxacin- metronidazole ligands showed 
better activities against the tested microrganisms 
than the free antibiotics used. The better activity of 
the metal complexes was due to chelation, which 
reduces the polarity of the metal atom and increases 
lipophilic character, favoring its permeation 
through lipid layers of the organism membrane 
(Matangi et al., 2012). The cobalt and the 
manganese complexes [Co(OFL)(MET)(H2O)2] 
and [Mn(OFL)(MET)(H2O)2]. H2O exhibited the 
best activities at the concentrations of 100µg/ml. 
However, the cobalt complexes still showed 
appreciable activity at a lower concentration of 
1µg/ml against Staphylococcus aureus and 
Salmonella typhi. 
It was observed that free metronidazole did not 
show antibacterial activity against the tested 
clinical strains of microorganisms used this might 
be attributed to the nature of the strain and the 
belief that, pathogens transmitted from the hospital 
environment are often resistant to commonly-used 
antibiotics (Urszula et al., 2015). Nevertheless, it 
showed good activity against the fungus used 
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Table 4: Antimicrobial activities of Ofloxacin,Metronidazole ligands and their metal (II) complexes 
Compound/Conc  K.P S.A  ETEC  M.M  S.T L.A EPEC T.R 
Ofloxacin 100µg/ml 23±0.11 - 16±0.00 25±0.22 30±0.00 20±0.00 30±0.00 - 
1µg/ml - - - - - - - - 
0.01µg/ml - - - - - - - - 
+C 20±0.00 14±0.00 24±0.00 10±0.00 16±0.00 26±0.00 24±0.00 28±0.00 
-C - -    -  - - - - - 
Metronidazole              
100µg/ml  - -     - - - - - 24±0.67 
1µg/ml - -     - - - - - - 
0.01µg/ml - -     - - - - - - 
+C 20±0.00 14±0.00 24±0.00 10±0.00 16±0.00 26±0.00 24±0.00 28±0.00 
-C - -     - - - - - - 
[Cu(OFL)(MET)(H2O)2] 
     
   
100µg/ml  26±0.00 11±0.33     - 26±0.33 32±1.54 23±0.88 30±0.93 38±0.77 
1µg/ml - -     - - - - - - 
25µg/ml - -     - - - - - - 
+C 20±0.00 14±0.00 24±0.00 10±0.00 16±0.00 26±0.00 24±0.00 28±0.00 
-C - - - - - - - - 
[Ni(OFL)(MET)(H2O)2]              
100µg/ml  24±0.67 - - 23±0.67 - 16±0.32 30±0.23 40±0.02 
1µg/ml - - - - - - - - 
0.01µg/ml - - - - - - - - 
+C 20±0.00 14±0.00 24±0.00 10±0.00 16±0.00 26±0.00 24±0.00 28±0.00 
-C - - - - - - - - 
[Co(OFL)(MET)(H2O)2]              
100µg/ml  22±0.24 30±1.13 26±0.33 25±1.15 34±1.23 23±0.33 26±0.78 34±0.42 
1µg/ml - 25±0.55    - - 25±0.37 - - - 
0.01µg/ml - - - - - - - - 
+C 20±0.00 14±0.00 24±0.00 10±0.00 16±0.00 26±0.00 24±0.00 28±0.00 
-C - - - - - - - - 
[Mn(OFL)(MET)(H2O)2]. 
H2O           
   
100µg/ml  25±0.37 12±2.07 24±1.17 28±0.29 30±0.65 26±0.22 32±0.66 20±0.66 
1µg/ml - - - - - - - 18±0.54 
0.01µg/ml - - - - - - - - 
+C 20±0.00 14±0.00 24±0.00 10±0.00 16±0.00 26±0.00 24±0.00 28±0.00 
-C - - - - - - - - 
[Zn(OFL)(MET)(H2O)2]              
100µg/ml  26±1.45 - 30±0.67 - 32±0.55 - 30±0.19 40±0.33 
1µg/ml - - - - - - - - 
0.01µg/ml - - - - - - - - 
+C 20±0.00 14±0.00 24±0.00 10±0.00 16±0.00 26±0.00 24±0.00 28±0.00 
-C - -     -     -    - - - - 
Data are mean of three replicates (n = 3) ± standard error;  -C= DMSO, +C(for bacteria) = Gentamycin, +C for fungus = 
Tioconazole, K.P = Klebsiella pneumonae, S.A = Staphylococcus aureus, ETEC = Enterotoxigenic Escherichia coli,  M.M = 
Morganella morganii, S.T = Salmonella typhi, L.A = Leclercia adecarboxylata, EPEC = Enteropathogenic Escherichia 
coli, T.R = Trichophyton rubrum 
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The inactivity of metronidazole against 
the bacteria was complemented by its combination 
with ofloxacin which exhibited good antibacterial 
activity but show inactivity against the fungus. The 
antimicrobial activities of the mixed ofloxacin-
metronidazole antibiotics were certainly enhanced 
by coordination with metals as evidenced by the 
better zone of inhibitions of the complexes of 11-
34mm against the bacteria and 20-40mm against 
the fungus which is higher than 28mm exhibited by 




The mixed ligands of ofloxacin and 
metronidazole metal (II) complexes of Copper, 
Cobalt, Nickel, Manganese and Zinc have been 
prepared and characterized by the spectroscopic 
methods. From the analytical and spectral data, the 
ligands coordinated in bidentate form to the metal 
ions; ofloxacin through the carboxy group oxygen 
and the pyridone carbonyl oxygen and 
metronidazole via the imidazole nitrogen atom and 
the hydroxyl oxygen atom of the terminal ethanol 
group to give octahedral geometries. Antimicrobial 
screening showed that coordination of the mixed 
antibiotic ligands to the metals leads to 
enhancement of their antimicrobial activities with 
the cobalt complex [Co(OFL)(MET)(H2O)2]  
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